GSK plc GLAXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 583.95M | 2.34B | 845.86M | 2.71B | 1.93B |
| Total Depreciation and Amortization | 299.36M | 623.79M | -832.56M | 995.12M | 826.88M |
| Total Amortization of Deferred Charges | -- | -- | 292.59M | -- | -- |
| Total Other Non-Cash Items | 1.98B | 30.99M | 2.18B | -52.59M | 1.42B |
| Change in Net Operating Assets | 751.75M | -1.46B | 541.30M | -660.72M | -1.38B |
| Cash from Operations | 3.61B | 1.54B | 3.03B | 3.00B | 2.80B |
| Capital Expenditure | -440.31M | -297.75M | -762.07M | -419.35M | -341.97M |
| Sale of Property, Plant, and Equipment | 4.03M | 36.38M | 17.29M | 6.74M | 6.68M |
| Cash Acquisitions | -916.87M | -1.90B | -57.19M | -1.16B | -4.01M |
| Divestitures | 20.14M | 330.08M | 1.33M | 1.35M | -37.40M |
| Other Investing Activities | 273.85M | -146.85M | -440.22M | -493.52M | -458.19M |
| Cash from Investing | -1.06B | -1.98B | -1.24B | -2.06B | -834.89M |
| Total Debt Issued | 273.00M | 1.20B | 552.00M | -80.00M | 645.00M |
| Total Debt Repaid | -958.00M | -73.00M | -79.00M | -62.00M | -1.57B |
| Issuance of Common Stock | 1.00M | 8.00M | 1.00M | 0.00 | 2.00M |
| Repurchase of Common Stock | -308.00M | -326.00M | -252.00M | -317.00M | -561.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -975.94M | -866.30M | -859.16M | -876.46M | -876.30M |
| Other Financing Activities | -430.00M | 104.00M | -432.00M | -206.00M | -230.00M |
| Cash from Financing | -2.88B | 366.46M | -1.14B | -1.77B | -3.17B |
| Foreign Exchange rate Adjustments | -9.40M | 2.69M | -54.53M | 79.56M | -34.73M |
| Miscellaneous Cash Flow Adjustments | 57.72M | -- | -- | -- | -- |
| Net Change in Cash | -284.59M | -68.71M | 595.82M | -761.85M | -1.24B |